We are excited to share that SwanBio is now part of Spur Therapeutics. Our potential first-in-class gene therapy candidate for adrenomyeloneuropathy (AMN) has joined Spur’s expanding pipeline of next-generation genetic medicines. Learn more at spurtherapeutics.com.
SwanBio Therapeutics
Biotechnology Research
Bala Cynwyd, Pennsylvania 6,616 followers
Researching & developing leading-edge gene therapies to deliver dramatic clinical efficacy for neurological diseases
About us
SwanBio is now part of Spur Therapeutics. Our potential first-in-class gene therapy candidate for adrenomyeloneuropathy (AMN) has joined Spur’s expanding pipeline of next-generation genetic medicines. Learn more at spurtherapeutics.com.
- Website
-
www.spurtherapeutics.com
External link for SwanBio Therapeutics
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Bala Cynwyd, Pennsylvania
- Type
- Privately Held
- Founded
- 2018
- Specialties
- Neurology and Gene Therapy
Locations
-
Primary
Get directions
150 Monument Rd
Suite 207
Bala Cynwyd, Pennsylvania 19004, US
-
Get directions
245 Main Street, 2nd Fl
Cambridge, Massachusetts 02142, US